Image of Jamie Bayona

Jaime Bayona, MD, MPH

Lecturer on Global Health and Social Medicine
603-277-0412

Jaime Bayona, MD, MPH is the Founding Director of Socios En Salud Sucursal Peru (SES), a Lima-based organization that has had significant impact on policies for prevention and treatment of drug-resistant tuberculosis (TB) and HIV and provided training and technical assistance around the world.

A leader in international health and social medicine, Dr Bayona is an authority on programmatic approaches to the control of multidrug-resistant TB and a long-time advocate for community-based primary care. He is the author of numerous publications related to TB control and treatment methods and is currently a co-investigator in a multi-institutional grant funded by the US National Institutes of Health to study the epidemiology of multidrug-resistant TB in Lima.

Dr Bayona received his MD in 1986 from The School of Medicine, National University of Trujillo in Peru and his MPH in 1992 from the Joint Center for Public Health Studies, College of Medicine, University of Wales, UK

Dr. Bayona's research focuses on the epidemiology of tuberculosis, multidrug-resistant tuberculosis, extremely drug-resistant tuberculosis, HIV/AIDS, community-based approaches to dealing with public health problems, social responsibility, and public health approaches in global health. He is also working on the performance evaluation of primary health system is several countries.

Expanding global HIV treatment: case studies from the field.
Authors: Authors: Furin JJ, Behforouz HL, Shin SS, Mukherjee JS, Bayona J, Farmer PE, Kim JY, Keshavjee S.
Ann N Y Acad Sci
View full abstract on Pubmed
Scaling up HIV treatment in Peru: applying lessons from DOTS-Plus.
Authors: Authors: Sebastian JL, Munoz M, Palacios E, Espiritu B, Mestanza L, Chalco K, Llaro K, Guerra D, Shin S, Bayona J.
J Int Assoc Physicians AIDS Care (Chic)
View full abstract on Pubmed
Multidrug-resistant tuberculosis management in resource-limited settings.
Authors: Authors: Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.
Emerg Infect Dis
View full abstract on Pubmed
Long-term follow-up for multidrug-resistant tuberculosis.
Authors: Authors: Shin SS, Furin JJ, Alcántara F, Bayona J, Sánchez E, Mitnick CD.
Emerg Infect Dis
View full abstract on Pubmed
Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
Authors: Authors: Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Expanding tuberculosis case detection by screening household contacts.
Authors: Authors: Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M.
Public Health Rep
View full abstract on Pubmed
rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in northern Lima, Peru.
Authors: Authors: Shin SS, Naroditskaya V, Sloutsky A, Werner B, Timperi R, Bayona J, Farmer PE, Becerra MC.
Microb Drug Resist
View full abstract on Pubmed
Learning from low income countries: what are the lessons? Improvement can occur even in resource constrained settings.
Authors: Authors: Sapag R, Bayona J.
BMJ
View full abstract on Pubmed
Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience.
Authors: Authors: Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P.
Soc Sci Med
View full abstract on Pubmed
Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Authors: Authors: Vásquez-Campos L, Asencios-Solis L, Leo-Hurtado E, Quispe-Torres N, Salazar-Lindo E, Bayona J, Becerra MC.
Int J Tuberc Lung Dis
View full abstract on Pubmed